key: cord-0744045-2byh7ztu authors: Amsei, Thamiris Quiqueto Marinelli; Gorayeb-Polacchini, Fernanda Salomão; Caldas, Heloisa Cristina; Fernandes-Charpiot, Ida Maria Maximina; Ferreira-Baptista, Maria Alice Sperto; Abbud-Filho, Mario title: Impact of the COVID-19 Pandemic on Kidney Transplant and on Chronic Dialysis Patients date: 2022-04-11 journal: Transplant Proc DOI: 10.1016/j.transproceed.2022.02.061 sha: 24ffdcca373ec40992cfd322752b1465dbc21a5f doc_id: 744045 cord_uid: 2byh7ztu Background The reported fatality rates of SARS-CoV-2 infection in patients receiving maintenance dialysis or kidney transplant are higher than in the general population. The aim of this study was to evaluate the impact of SARS-COV2 infection in chronic dialysis patients (DP) compared with kidney transplant recipients (KTxR). Method Study evaluating 266 COVID-19 positive patients (112 DP and 154 KTxR) in a single center from March 1, 2020 to June 31, 2021. All patients were confirmed for COVID-19 infection by RT- PCR or antigen test. Results KTxR were younger (49 ± 12.4 vs. 61 ± 14.6; p < 0.0001) and had significantly fewer coexisting disorders than the DP. A higher percentage of KTxR required hospitalization (70% vs. 49.4%, p = 0.002), intensive care unit necessity (39% vs. 25%, p = 0.01). The fatality rates were 24% in both groups. Discussion There is no consensus among studies, about the higher fatality rate between KTxR versus DP that develop COVID-19. In our study, we also did not find a different fatality rate. Conclusion In spite of KTxR being younger and with fewer coexisting disorders, they presented a higher hospitalization and intensive care unit necessity rate, but a similar fatality rate compared with DP. This study highlights COVID-19 infection affecting kidney transplant and dialysis patients. We emphasized the demographic characteristics and outcomes of the COVID-19 infection in these populations. higher hospitalization and intensive care unit necessity rate, but a similar fatality rate compared with DP. COVID-19 was first reported in Wuhan in December of 2019 and became a world health emergency [1] . On February 2020, the first case of COVID-19 was reported in Brazil, which then became one of the most affected countries. The country had more than 21 million confirmed cases and more than 600 thousand deaths, corresponding to an overall case-fatality rate of 2.8% [2] . Because of underlying chronic kidney disease associated with comorbid conditions, chronic dialysis patients (DP) and kidney transplant recipients (KTxR) are high-risk for COVID-19 disease [3] . Brazil has the world's third highest number of chronic DP and the second absolute number of KTxR worldwide, which both focus attention on COVID-19 in these Brazilian cohorts [4] [5] . The long-term use of immunosuppression in KTxR is a matter of debate, some arguing that the immunosuppression would predispose them to a greater risk of severe infection [6] . Others speculate that immunosuppressive therapy may be protective against the COVID-19-induced cytokine storm [7] . DP are at high risk of COVID-19 infection, because they require frequent traveling to the dialysis facility using public transportation, and because they have close contact with the staff and other patients within the dialysis unit [8] . The aim of the study was to compare the outcomes of DP and KTxR with COVID-19 disease. We conducted a prospective observational single-center study, and data was collected from registry The parametric data group comparisons were made using a t-test or one-way analysis of variance (ANOVA). Group comparisons of nonparametric data were carried out using the Mann-Whitney or Kruskal-Wallis test. The data were analyzed using the Statistic 9.0 software (Statsoft Inc., Tulsa, OK, USA). Data are presented as mean ± standard deviation, and p < 0.05 was considered statistically significant. Of 511 COVID-19 suspected patients, 112 tested positive for COVID-19 by RT-PCR. The majority, 85%, was undergoing hemodialysis, and 15% were undergoing home peritoneal dialysis, having an average dialysis time of 43±41 months. Out of 526 KTxR tested, 154 had COVID-19 confirmed by RT-PCR (89%) or Ag-Test (11%). Of the COVID-19 positive KTxR, 79% were from deceased donors, with an average time of transplantation around 85±67 months. Immunossupression regimen was based in calcineurin inhibitors /ICN (71%) associated with mycophenolic acid/MPA (51%) or mammalian target of rapamycin inhibitors/mTORi (5.3%) or azathioprine/AZA (13%). Only 1.3% were on steroid free regimen. KTxR were younger, presented higher body mass index (BMI), and had less coexisting disorders: cardiovascular disease, hypertension, diabetes mellitus, and lung disease (Table 1) when compared with DP. Classical symptoms, such as fever, cough, and dyspnea, were more frequent in the DP than KTxR. Changes in biochemistry, hematological, and inflammatory markers were higher in the KTxR compared with the DP. Interestingly, lower hemoglobin and higher alkaline phosphatases were seen more frequently in the DP (Table 1) . KTxR required more hospitalization and intensive care unit (ICU), and no significant differences were found between the two groups concerning the fatality rate. The mean age between the deaths was higher in the DP group (Table 1) . Incidence rate of COVID-19 in the DP group was 2,240/10,000 patients with a mortality rate of 480/10,000 patients and a fatality rate 24%. In the KTxR group, the incidence rate was 1,750/10,000 patients with a mortality rate of 420.4/10,000 patients and a fatality rate of 24%. Incidence of COVID-19 infection in the general Brazilian population is 1,002.8/10,000 inhabitants, much lower than compared to the DP group (2,240/10,000 inhabitants) and the KTxR group (1,750/10,000 inhabitants). The highest incidence found in the DP may be due to the higher exposure during the shared transport and frequently close contact with staff and others patients, and in KTxR may be because of the consultation and hospitalization contamination [2, 9] . The general Brazilian population mortality was of 28/10,000 inhabitants and a fatality rate of 2.8% [5] , lower than the DP (mortality of 480/10,000 inhabitants and a fatality rate of 24%) and the KTxR (mortality rate of 420.4/10,000 inhabitants and a fatality rate of 24%), showing the higher risk of death for COVID-19 infection in these populations. Even with the higher incidence and mortality rates observed in the DP and the KTxR, their fatality rate did not differ. The KTxR and DP fatality rates (24%) in our study were similar in the DP 7 (24.9%) of the Spanish study, but higher in the KTxR (18.6%) found in the same Spanish study [11] . However, these findings were higher in both DP and KTxR compared to the multicenter European group study (21.2% and 20.2%, respectively) [10] . The high fatality rate found in DP patients can be explained by the fact that this population is older and has more coexisting disorders (Table 1) in agreement with other studies [3, [10] [11] . In spite of the KTxR being younger and with fewer comorbidities than the dialysis group, these results are similar to the multicenter European group study [10] . Comparing other outcomes, the KTxR presented more hospitalization and more ICU need than the DP. In addition, a European study comparing the mortality between the KTxR and DP shows that the mortality risk in KTxR with COVID-19 was 28% higher compared with the selected matched group of DP [10] . A recent study from Madrid reported some inflammatory markers as predictors of severe COVID-19 in the general population [12] . A COVID-19 analysis in dialysis patients in the same hospital in Brazil showed that those markers were significantly higher in the COVID-19 severe form of the disease, while hemoglobin and lymphocyte counts were significantly lower [9]. Our study found that the neutrophil lymphocyte ratio, C-reactive protein, lactic dehydrogenase, and liver enzymes were more frequent higher in the KTxR compared with the DP, which could mean more severe disease. In conclusion, our results suggest that the clinical spectrum of COVID-19 between KTxR and DP have much higher fatality and mortality rates compared with the general Brazilian population. Additionally, KTxR, in spite of having less comorbidities and younger age, had similar mortality and fatality rates, as well as incidence of COVID-19, compared with the DP group. A novel coronavirus from patients with pneumonia in China Brazilian Ministry of Health. Coronavírus Brasil. Painel de casos de doença pelo coronavírus 2019 (COVID-19) no Brasil pelo Ministério da Saúde COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration Censo de Diálise da Sociedade Brasileira de Nefrologia 2020 Registro Brasileiro de Transplantes (RBT) 2020. Dimensionamento dos Transplantes no Veículo Oficial da Associação Brasileira de Early experience with COVID-19 in kidney transplantation The trinity of COVID-19: immunity, inflammation and intervention Practical indications for the prevention and management of SARS-CoV-2 in ambulatory dialysis patients: lessons from the first phase of the epidemics in Lombardy Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe Report of the COVID-19 Registry of the Spanish Society of Nephrology (SEN) Main differences between the first and second waves of COVID-19 in Madrid Spain 63 *Calculations: The incidence, mortality and case fatality rates were calculated as follows:Incidence = number of cases from 03/01/2020 until the end of the current report (06/31/2021) / number of exposed people per 10,000. Mortality = number of deaths due to COVID-19/number of exposed people per 10,000. Fatality = (number of confirmed deaths due to COVID-19/number of confirmed COVID-19 cases) *100.